Sustainability Report

Overview

The report describes Lotus Pharmaceutical's 2023 sustainability progress across environmental, social, and governance topics. Consolidated emissions across major Taiwan and South Korea operations totaled 15,439.8930 ton CO2e, alongside disclosures on energy, water consumption, waste, and a 2050 net-zero ambition. The company reported 1,131 employees in Taiwan and South Korea and 36% female representation on the board. Grant Thornton provided limited assurance over selected sustainability indicators and Scope 1 and Scope 2 GHG information.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2023
Period: 1 January 2023 – 31 December 2023
Language: English
Pages
File size
Restatement: Disclosed

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level

Materiality

Assessment
Basis
Matrix

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services

Overview